Zobrazeno 1 - 10
of 41
pro vyhledávání: '"WW Bolten"'
Autor:
S Zaun, Maria Blettner, R. Kreienberg, C. Jackisch, Peter S. Klein, Winfried Rief, Nadia Harbeck, P. Hadji, WW Bolten, Diethelm Wallwiener, K König, H. J. Hindenburg
Publikováno v:
Cancer Research. 72:P6-09
Background: Aromatase Inhibitors (AI) are well established as adjuvant treatment for postmenopausal (PMP) women with hormone receptor positive (HR+) early breast cancer (EBC). However, phase III clinical trials have reported higher rates of arthralgi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5dbd9845d0bfad942595cac643249ec3
https://doi.org/10.1158/0008-5472.sabcs12-p6-09-08
https://doi.org/10.1158/0008-5472.sabcs12-p6-09-08
Publikováno v:
Geburtshilfe und Frauenheilkunde. 68:977-985
OBJECTIVE: It is well documented that aromatase inhibitors (AI) are superior to tamoxifen as an adjuvant endocrine therapy in postmenopausal women with hormone receptor-positive breast cancer. However, compared with tamoxifen, an elevated incidence o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9693948458f7ee432a3a042fb8ac0c9f
https://doi.org/10.1055/s-2008-1038945
https://doi.org/10.1055/s-2008-1038945
Autor:
WW Bolten, C. Jackisch, H. J. Hindenburg, S Zaun, P. Hadji, Maria Blettner, D. Wallwiener, Peter S. Klein, K König, Winfried Rief, R. Kreienberg, Nadia Harbeck
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 25(2)
5 Office-based Professional Association Gynecologic Oncologists e.V. in Germany (BNGO e.V.), Berlin; 6 Background: This prospective study evaluated the relationship between arthralgia and compliance during the first year of adjuvant anastrozole thera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79b57b7f4a445a41bd82331014d26ef8
https://pubmed.ncbi.nlm.nih.gov/24355487
https://pubmed.ncbi.nlm.nih.gov/24355487
Autor:
N Harbeck, H. J. Hindenburg, Peter S. Klein, WW Bolten, K König, Maria Blettner, D Wallwiener, R Kreienberg, C Jackisch, Winfried Rief, P. Hadji, S Zaun
Publikováno v:
Senologie - Zeitschrift für Mammadiagnostik und -therapie. 9
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::489ce234d8454357ad2a66c21a4ff508
https://doi.org/10.1055/s-0032-1313440
https://doi.org/10.1055/s-0032-1313440
Autor:
N Harbeck, K König, Maria Blettner, WW Bolten, C Jackisch, R Kreienberg, H.-J. Lück, D Wallwiener, H. J. Hindenburg, Winfried Rief, P. Hadji, S Zaun
Einführung: Aromatasehemmer (AH) der 3. Generation sind in der adjuvanten Therapie postmenopausaler Frauen mit HR+ Brustkrebs etabliert. Jedoch gehen AH häufiger als Tamoxifen mit Arthralgien einher. Die COMPACT-Studie soll klären helfen, welchen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb45989b70cc5e6ea0dfbd20fd7c4ee0
Autor:
K König, D Wallwiener, Winfried Rief, N Harbeck, P. Hadji, S Zaun, Maria Blettner, R Kreienberg, WW Bolten, C Jackisch
Publikováno v:
Senologie - Zeitschrift für Mammadiagnostik und -therapie. 7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5372862911812ff36f8bf878982915e
https://doi.org/10.1055/s-0030-1262052
https://doi.org/10.1055/s-0030-1262052
Autor:
Robert E. Coleman, D. Merkel, Nicolai Maass, Mark Lansdown, Christian Jackisch, WW Bolten, S. Dale, Peyman Hadji
Publikováno v:
Cancer treatment reviews. 34(3)
It is well documented that the aromatase inhibitors (AIs) are superior to tamoxifen as adjuvant endocrine therapy in postmenopausal women with hormone receptor-positive breast cancer. However, compared with tamoxifen, an elevated incidence of arthral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7a6926f85ccfb81d71dcab1c025ba3a
https://pubmed.ncbi.nlm.nih.gov/18082328
https://pubmed.ncbi.nlm.nih.gov/18082328
Autor:
H. J. Lueck, Maria Blettner, P. Hadji, Winfried Rief, WW Bolten, Peter S. Klein, H. J. Hindenburg, Nadia Harbeck, C. Jackisch, R. Kreienberg, K König, S Zaun
Publikováno v:
Cancer Research. 71:PD06-07
Introduction: Aromatase inhibitors (AI) are well established as adjuvant endocrine treatment for postmenopausal (PMP) women with HR+ early breast cancer (EBC). However, according to retrospective data, compliance to adjuvant endocrine therapy for EBC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a40566d766cf4c3dc33bd7d9faa8ebb2
https://doi.org/10.1158/0008-5472.sabcs11-pd06-07
https://doi.org/10.1158/0008-5472.sabcs11-pd06-07
Autor:
Winfried Rief, Nadia Harbeck, K König, S Zaun, WW Bolten, Diethelm Wallwiener, H. J. Hindenburg, P. Hadji, Maria Blettner, R Kreienberg, C. Jackisch, Peter S. Klein
Publikováno v:
Annals of the Rheumatic Diseases. 71:717.9-717
Background Aromatase inhibitors (AI) are well established as adjuvant endocrine treatment for postmenopausal women with hormone receptor-positive (HR+) early breast cancer (EBC). Drug-induced myalgia or arthralgia is among the most frequently reporte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::45c9cc84069fedebeab74c10a19ff49f
https://doi.org/10.1136/annrheumdis-2012-eular.1386
https://doi.org/10.1136/annrheumdis-2012-eular.1386
Autor:
Bolten WW; Rheumatologie, Klaus-Miehlke Klinik, Leibnizstr. 23, 65191, Wiesbaden, Deutschland. wbolten@em.uni-frankfurt.de., Krüger K; Praxiszentrum St. Bonifatius, St.-Bonifatius-Str. 5, 81541, München, Deutschland.
Publikováno v:
Zeitschrift fur Rheumatologie [Z Rheumatol] 2016 Aug; Vol. 75 (6), pp. 595-8.